OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to Patrick J. McEnany, President and Chief Executive Officer of Catalyst Pharmaceuticals, Inc. - Sanders Investigates a $375,000 Price Spike on Old Drug

Letter

Date: Feb. 4, 2019
Location: Washington, DC
Issues: Health and Health Care

Only available in PDF format; please see source to view document.


Source
arrow_upward